52536-09-1

Basic information

• Product Name: 3-Hydroxypyridine sodium salt
• Synonyms: 3-HYDROXYPYRIDINE SODIUM SALT;sodium pyridin-3-olate;Sodium pyridine-3-olate;3-Hydroxypyridine sodium salt,98%;3-Hydroxypyridine so
• CAS NO: 52536-09-1
• Molecular Formula: C₅H₄NO*Na
• Molecular Weight: 117.08
• EINECS: 257-995-1
• Product Categories: Pyridines derivates
• Mol File: 52536-09-1.mol
• Article Data: 1

Chemical Properties

• Melting Point: 300 °C
• Boiling Point: 318.9 °C at 760 mmHg
• Flash Point: 146.6 °C
• Appearance: /solid
• Density: g/cm³
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 3-Hydroxypyridine sodium salt(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Hydroxypyridine sodium salt(52536-09-1)
• EPA Substance Registry System: 3-Hydroxypyridine sodium salt(52536-09-1)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 37/39-26
• Hazardous Substances Data: 52536-09-1(Hazardous Substances Data)

Usage

Chemical Properties

beige powder

InChI:InChI=1/C5H5NO.Na/c7-5-2-1-3-6-4-5;/h1-4,7H;/q;+1/p-1

Upstream product

• 109-00-2 3-HYDROXYPYRIDINE 

Downstream Products

• 76594-24-6 2-(3'-pyridyloxy)-3-nitropyridine 
• 1364440-81-2 2,4-bis-(3-pyridyloxy)benzonitrile 
• 1364440-74-3 C₁₂H₇FN₂O 
• 936220-68-7 2-(Pyridin-3-yloxy)-benzonitrile 

Relevant articles and documents

NOVEL CYCLOHEXANE DERIVATIVE, PRODRUG THEREOF AND SALT THEREOF, AND THERAPEUTIC AGENT CONTAINING THE SAME FOR DIABETES

A cyclohexane derivative having the function of reducing a blood sugar level and having preferable properties required of medicines, such as long-lasting drug activity, metabolic stability, and safety; and a medicinal composition for use in the prevention or treatment of diseases attributable to hyperglycemia, such as diabetes, e.g., insulin dependent diabetes mellitus (type 1 diabetes) or noninsulin-dependent diabetes mellitus (type 2 diabetes), complications of diabetes, and obesity. The derivative is a compound represented by the formula (I): (wherein A is -O-, -CH2-, or -NH-; n is an integer selected between 0 and 1; R6 and R7 each independently is hydrogen or C1-6 alkyl; m is an integer selected among 1-3; Q is selected among the following formulae Q1 to Q5; Ar1 is optionally substituted arylene or optionally substituted heteroarylene, provided that the heteroarylene may be bonded to an aromatic carbocycle or aromatic heterocycle to form a fused ring; and Ar2 is optionally substituted aryl or optionally substituted heteroaryl), a prodrug of the compound, or a pharmaceutically acceptable salt of either. Also provided are a medicine, a medicinal composition, or the like each containing the compound.